자궁경부의 전암 병변 및 침윤성암종에서 Mikdine의 발현 양상
Immunohistochemical Analysis of Midkine Expression inPreinvasive and Invasive Squamous Cell Neoplasia of theUterine Cervix
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Background : Midkine (MK) is a member of the heparin-binding growth factor family. Overexpression of MK is observed not only in cancerous tissue but also in precancerous lesions of the colon and the prostate. Using immunohistochemical methods, we investigated MK expression in preinvasive and invasive neoplasia of the uterine cervix. Methods : We performed immunohistochemical analysis of archived cone biopsy and hysterectomy specimens from 161 squamous cell lesions of the uterine cervix (29 cervical intraepithelial neoplasia 1 (CIN1), 35 CIN2, 49 CIN3, 30 microinvasive squamous cell carcinomas (MIC), and 18 invasive squamous cell carcinoma). In addition, we examined if there is a correlation between MK expression and status of human papilloma virus infection determined by a commercially available DNA chip. Results : None of the normal cervical mucosa showed MK immunostaining. The level of MK expression gradually increased according to the histologic grade. Moderate and strong expressions were most frequently observed in cervical tissue with CIN3 and MIC. MK immunostaining was more accentuated in the invasive border of MIC. Conclusion : MK may play a functional role in the disease progression of cervical squamous cell neoplasia.
참고문헌 (30)
- "Concomitant synthesis of growth factorsand their receptors:an aspect of malignant transformation", 33, pp.941~3 (1984)
- "Growth factors in development,transformation,and tumorigenesis", 64, pp.271~80 (1991)
- "Growth factors and cancer", 254, pp.1146~53 (1991)
- "cDNA cloning andsequencing of a new gene intensely expressed in early differentiationstages of embryonal carcinoma cells and in mid-gestation periodof mouse embryogenesis", 151, pp.1312~8 (1988)
- "Midkine and pleiotrophin in neuraldevelopment and cancer", 204, pp.127~143 (2004)
- "Increased midkine gene expression in human gastrointestinal cancers", 86, pp.655~661 (1995)
- "A new family of heparinbinding growth", differentiation factors:increased midkine expressionin Wilms’ tumor and other human carcinomas, 1993, pp.53, 1281~5
- "Differential expression of pleiotrophin and midkine in advanced neuroblastomas", 55, pp.1792~1797 (1995)
- "Reciprocal expression of pleiotrophinand midkine in normal versus malignant lung tissues", 9, pp.463~6 (1993)
- "Midkine and pleiotrophin expression in normal and malignantbreast tissue", 74, pp.1584~90 (1994)
- "The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers", 56, pp.2515~2518 (1996)
- "Association of an intronic polymorphism in the midkine (MK) gene with human sporadic colorectal cancer", 180, pp.159~163 (2002)
- "Midkine expression in human breast cancer: expression of truncated form", 43, pp.1~6 (1997)
- "Expression of truncatedmidkine in human colorectal cancers", 106, pp.287~291 (1996)
- "Truncated midkine induces transformation of cultured cells and short latency of tumorigenesis in nude mice", 219, pp.83~89 (2005)
- "Exon skipping of midkine premRNA is enhanced by intronic polymorphism in a colon cancer cell line", 207, pp.89~93 (2004)
- "Serum midkine levels are increased in patients with various types of carcinomas", 83, pp.701~706 (2000)
- "Corrrelation of elevated plasma levels of two structurally related growth factors, heparin affin regulatory peptide and midkine, in advanced solid tumor patients", 28, pp.319~324 (2004)
- "Morpholino antisense oligomer targeting human midkine: its application for cancer therapy", 114, pp.490~497 (2005)
- "Antisense oligodeoxynucleotide targeted to midkine, a heparin-binding growth factor, suppresses tumorigenicity of mouse rectal carcinoma cells", 61, pp.8486~8491 (2001)
- "Expression of midkine in the early stage of carcinogenesis in human colorectal cancer", 79, pp.179~184 (1999)
- "Expression of midkine in benign, premalignant and malignant vulvar tumors", 17, pp.148~152 (2002)
- "Immunohistochemicalanalysis of midkine expression in human prostate carcinoma", 57, pp.253~257 (1999)
- "Immunohistochemical and quantitative competitive PCR analyses of midkine and pleiotrophin expression in cervical cancer", 88, pp.289~297 (2003)
- "The midkine mRNA expressionin invasive cervical cancer", 11, pp.123~130 (2000)
- "Distribution and prevalence of human papillomavirus genotypes in routine pap smear of 2,470 Korean women determined by DNA chip", 13, pp.2153~2156 (2004)
- "Midkine a retinoic acid-inducible growth", differentiation factor:immunohistochemical evidence for the function and distribution, 1993, pp.159, 392~402
- "An angiogenicrole for the neurokines midkine and pleiotrophin in tumorigenesis", 57, pp.1814~1819 (1997)
- "Immunohistochemical and in situ hybridization analyses of midkine expression in thyroid papillary carcinoma", 13, pp.1060~1065 (2000)
- "Pleiotrophin and midkine,a family of mitogenicand angiogenic heparin-binding growth and differentiation factors", 6, pp.44~50 (1999)
